Collagen fibrillar construction

US9518106B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9518106-B2
Application numberUS-201514664137-A
CountryUS
Kind codeB2
Filing dateMar 20, 2015
Priority dateApr 11, 2008
Publication dateDec 13, 2016
Grant dateDec 13, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods and compositions are described for organizing collagen into fibrillar networks, e.g, short and long-range organization. Collagen produced by the disclosed methods can be used for tissue engineering.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of producing an organized array of collagen fibrils, the method comprising: applying a tension to a plurality of collagen fibrils in a solution, wherein the tension is controlled to generate a strain of about 1% to about 10% such that a controlled load on collagen monomers in the solution is produced; and adding a collagen lytic protease to the solution, thereby producing an organized array of collagen fibrils. 2. The method of claim 1 , further comprising neutralizing the pH of the solution. 3. The method of claim 2 , further comprising neutralizing the pH of the solution at about 10° C. to about 39° C. 4. The method of claim 1 , wherein the tension is applied to both ends of the plurality of collagen fibrils. 5. The method of claim 4 , further comprising adding supplemental collagen monomers to the solution continuously when applying the tension. 6. The method of claim 5 , wherein the collagen lytic protease and the supplemental collagen monomers are added simultaneously to the solution. 7. The method of claim 5 , wherein the collagen lytic protease and the supplemental collagen monomers are added sequentially to the solution. 8. The method of claim 5 , wherein the collagen lytic protease and the supplemental collagen are added more than once to the solution. 9. The method of claim 1 , further comprising organizing the array of collagen fibrils into a tissue. 10. The method of claim 5 , further comprising continuously extending a collagen fibrillar structure at a rate of from about 0.1 μm/min to about 100 μm/min. 11. The method of claim 10 , further comprising adding collagen lytic protease to the solution while extending the collagen fibrillar structure. 12. The method of claim 10 or 11 , further comprising extending the collagen fibrillar structure in the presence of a co-nonsolvency agent. 13. The method of claim 12 , wherein the co-nonsolvency agent is polyethylene glycol, hyaluronic acid, a glycosaminoglycan, a proteoglycan, or a combination thereof. 14. The method of claim 13 , wherein the proteoglycan is lumican, decorin, biglycan, perlecan, versican, fibromodulin, aggrecan, sydecan or a combination thereof. 15. The method of claim 1 or claim 11 , wherein the collagen lytic protease is a bacterial collagenase, a matrix metalloproteinase, or cathepsin. 16. The method of claim 1 , wherein the solution further comprises a collagen binding agent. 17. The method of claim 16 , wherein the collagen binding agent is a proteoglycan, a glycoprotein, a collagen-binding portion thereof, or a combination thereof. 18. The method of claim 1 , wherein the controlled load on each collagen monomer is from 1.0 piconewtons to 10.0 piconewtons. 19. The method of claim 1 , wherein the controlled load on each collagen monomer is greater than 10.0 piconewtons. 20. The method of claim 1 , further comprising adding a cross-linking agent to the solution. 21. The method of claim 20 , wherein the cross-linking agent is added before applying the tension. 22. The method of claim 20 , wherein the cross-linking agent is added after applying the tension. 23. The method of claim 20 , wherein the cross-linking agent is formaldehyde, hexamethylene diisocyanate, glutaraldehyde, polyepoxy compounds, gamma irradiation, or ultraviolet irradiation with riboflavin.

Assignees

Inventors

Classifications

  • C08H1/06Primary

    derived from horn, hoofs, hair, skin or leather · CPC title

  • derived from leather or skin {, e.g. gelatin} · CPC title

  • C07K14/78Primary

    Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG] · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9518106B2 cover?
Methods and compositions are described for organizing collagen into fibrillar networks, e.g, short and long-range organization. Collagen produced by the disclosed methods can be used for tissue engineering.
Who is the assignee on this patent?
Univ Northeastern
What technology area does this patent fall under?
Primary CPC classification C08H1/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).